We, the European Liver Patients Association representing patients with liver disease in Europe, would like to draw attention to the urgent public health problem of access to the latest medical therapies for the treatment of patients with hepatitis C.

In 2010, HCV mortality in the EU reached 57.000 with tendencies to grow steadilyi. Moreover, HCV-related complications have caused...

Open Letter